Quiz|Articles|September 30, 2026

Psychiatric Times

  • Vol 43, Issue 9

Earn CME Credit With Psychiatric Times: Test Your Knowledge

Listen
0:00 / 0:00

Key Takeaways

  • MAOIs are positioned as an effective option for refractory depression through monoamine augmentation, with practical emphasis on dietary restrictions and clinically significant drug–drug interactions.
  • Spirituality is framed as meaning-making and connectedness, highlighting historically limited incorporation into psychiatric practice despite relevance to mental health outcomes.
SHOW MORE

Don't miss out on these CME articles! Test your knowledge here.

If you need CME credit, check out these exclusive articles from Psychiatric Times before they expire. Answer the quiz questions to test your knowledge.

Successfully Prescribing MAOIs for Depression

Shalom Feinberg, MD

Expiration Date: January 20, 2027

Monoamine oxidase inhibitors (MAOIs) offer unique efficacy in treatment-resistant depression by increasing serotonin, norepinephrine, and dopamine concentrations. They are effective in refractory cases despite dietary restrictions and potential interactions.

1. Which isoform's inhibition is primarily associated with antidepressant effects?


Learn more here: https://www.psychiatrictimes.com/view/successfully-prescribing-maois-for-depression

Psychiatry and Spirituality: Exploring the Intersections of Meaning and Mental Health

Marieta Pehlivanova, PhD; Marina Weiler, PhD; J. Kim Penberthy, PhD, ABPP; and Philip J. Cozzolino, PhD

Expiration Date: February 20, 2027

Spirituality, often defined as the search for meaning and connection beyond the self, is a fundamental dimension of human experience that has been historically overlooked in psychiatric practice.

2. Which best describes the difference between religiosity and spirituality?


Learn more here: https://www.psychiatrictimes.com/view/psychiatry-and-spirituality-exploring-the-intersections-of-meaning-and-mental-health

Movement Disorders in Psychiatric Practice

Haitham Salem, MD, PhD; Gabriel A. de Erausquin, MD, PhD; and Antonio L. Teixeira, MD, PhD

Expiration Date: March 20, 2027

Movement disorders in psychiatry often result from antipsychotic use, causing hyperkinetic and bradykinetic symptoms, including tardive dyskinesia and parkinsonism.

3. Which class of drugs is most commonly associated with the development of tardive dyskinesia?


Learn more here: https://www.psychiatrictimes.com/view/movement-disorders-in-psychiatric-practice

A Critical Catch: Catatonia Due to Multiple General Medical Conditions

Erica Taylor, MD, MPH; Drew Cumming, MD; and James A. Bourgeois, OD, MD

Expiration Date: April 20, 2027

Catatonia can also occur comorbidly with other acute neuropsychiatric presentations such as delirium and neuroleptic malignant syndrome.

4. In the context of DSM-5-TR, why can diagnosing catatonia be challenging in patients with medical illness?


Learn more here: https://www.psychiatrictimes.com/view/a-critical-catch-catatonia-due-to-multiple-general-medical-conditions

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

Andrew Nguyen, MD, MSc; and Ayal Schaffer, MD, FRCPC

Expiration Date: May 20, 2027

Many clinicians remain unsure about the most effective way to approach concerns about suicide in bipolar disorder (BD). This uncertainty stems not only from the inherent complexity of suicide risk assessment in BD but also from the lack of clear guidance on which interventions are both tailored to BD and grounded in a broader suicide prevention approach.

5. What is the estimated suicide rate in individuals with bipolar disorder compared with the general population?


Learn more here: https://www.psychiatrictimes.com/view/through-the-peaks-and-valleys-assessing-and-addressing-suicide-risk-in-bipolar-disorder

Are you interested in writing a CME article? Email us at PTEditor@mmhgroup.com!


Related to this article